About Fiagon
Fiagon is a company based in Hennigsdorf (Germany) founded in 2007 by Dirk Mucha was acquired by Hemostasis in May 2022. Fiagon has raised $8.5 million across 4 funding rounds from investors including Intersect ENT, German Startups Group and longone.com. Fiagon offers products and services including VirtuEye, Navigation System, and Navigation Instruments. Fiagon operates in a competitive market with competitors including Augmedics, Proprio, eCential Robotics, MRI Interventions and Endomag, among others.
- Headquarter Hennigsdorf, Germany
- Founders Dirk Mucha
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website fiagon.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Hemostasis (May 2022)
- Legal Name Fiagon Gmbh
- Total Equity Funding$8.5M (USD)
in 4 rounds
- Latest Funding Round$8.5M (USD), Series D
Mar 2016
- InvestorsIntersect ENT
& 5 more
- Acquired by
Products & Services of Fiagon
Fiagon offers a comprehensive portfolio of products and services, including VirtuEye, Navigation System, and Navigation Instruments.
Contactless tool for fast patient registration in surgical settings.
Electromagnetic system for precise ENT and CMF surgery operations.
Flexible instruments with additional functions like suction for accurate navigation.
Apps and channels of Fiagon
its YouTube channel Fiagon Navigation has 200 subscribers and 23 videos.
Videos from Fiagon
The most watched videos on Fiagon's YouTube channel, Fiagon Navigation (200 subscribers). Click a video to play it here.
More on Fiagon Navigation.
Funding Insights of Fiagon
Fiagon has successfully raised a total of $8.5M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $8.5 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.5M
- Total Rounds 4
- Last Round Series D — $8.5M
- Investors Count 4
All 4 funding rounds of Fiagon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | $8.5M | Series D | – | – | |
| Jun 2015 | – | Series C | – | Cascara Ventures | – |
| Jun 2012 | – | Series B | – | Cascara Ventures | – |
| Jan 2009 | – | Seed | – | – |
6 investors in total: 6 institutional.
Investors in Fiagon
Fiagon has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Intersect ENT, German Startups Group and longone.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm investing in early & growth stage tech companies in Europe | – | german-startups.com | Frankfurt Am Main, Germany | |
Early-stage investments are provided by Cascara Ventures in life sciences. | 2016 | cascaraventures.com | - | |
- | – | htgf.de | - | |
- | – | longone.com | - | |
Drug-releasing implants for sinusitis treatment are developed. | 2003 | intersectent.com | Menlo Park, United States | |
Develops and manufactures hemostatic products for surgical bleeding control and patient care. | 2006 | hemostasisllc.com | Saint Paul, United States |
Investor details for Fiagon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fiagon
1 people are tracked at Fiagon (1 in leadership).
| Name | Role | Group |
|---|---|---|
Dirk Mucha | Co-Founder & CTO | Leadership |
Complete people profiles for Fiagon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Fiagon
5 dated milestones of Fiagon across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Fiagon is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $8.5M.
- Exit Acquired by Intersect ENT.
- Exit Acquired by Hemostasis.
Competitors of Fiagon
Fiagon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Proprio, eCential Robotics, MRI Interventions and Endomag, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| augmedics.com | 2014 | Yokneam Illit, Israel | $142.6M | – | Augmented reality systems for guiding surgical procedures are developed. | |
| propriovision.com | 2016 | Seattle, United States | $74.25M | 52 | Visualization systems for surgical procedures are developed using machine learning. | |
| ecential-robotics.com | 2009 | Gieres, France | $133.97M | – | Robotic surgery platform for bone procedures is developed. | |
| mriinterventions.com | 1998 | Irvine, United States | $16.67M | 108 | MRI-guided minimally invasive procedures for brain and heart are developed. | |
| endomag.com | 2007 | Cambridge, United Kingdom | $44.52M | – | Developer of a device for tumor localization | |
| centerlinebiomedical.com | 2014 | Cleveland, United States | $76.26M | – | Developer of surgical navigation and image guidance system for endovascular procedures | |
| avetasystem.com | 2016 | San Jose, United States | $23M | 57 | Manufacturer of hysteroscopy for operating rooms | |
| imris.com | 2005 | Minnetonka, United States | – | 100 | Surgical theatres with ceiling mounted mobile imaging devices to enhance intraoperative workflow | |
| clearpointneuro.com | 1998 | Irvine, United States | $18.35M | 38 | Software and hardware solutions for MRI-guided surgical planning are provided. | |
| fluoguide.com | 2018 | Copenhagen, Denmark | $13.95M | 11 | Surgery-targeting drugs for cancer patients are developed using fluorophores. |
Detailed competitors of Fiagon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fiagon
Complete news archive for Fiagon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Fiagon
10 companies that operate in the same segment as Fiagon (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 12.68 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.32 B | – | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fiagon
Fiagon was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Fiagon is headquartered in Hennigsdorf, Germany. It is registered at Hennigsdorf, Brandenburg, Germany.
Fiagon is a funded company, having raised a total of $8.5M across 4 funding rounds to date.
Fiagon was founded in 2007 in Hennigsdorf, Germany, within the medical devices sector. Clinical navigation systems are provided to healthcare providers for surgical applications, including ENT, oral and maxillofacial surgery, and neurosurgery. Electromagnetic tracking matrix algorithms and pointer technology are employed to maintain precision with flexible instruments. The CUBE virtual guidance platform is offered for ENT and skull base procedures, while proprietary FlexSensor technology supports specialized navigation solutions.
Fiagon's top competitors include Augmedics, Proprio and ClearPoint Neuro.
Fiagon offers VirtuEye, Navigation System, and Navigation Instruments.
Fiagon has 6 investors. Key investors include Intersect ENT, German Startups Group, longone.com, Cascara Ventures, and Hemostasis.
Fiagon operates through Fiagon Gmbh.
Yes. Fiagon was acquired by Hemostasis in May 2022.